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ABSTRACT
An acute coronary syndrome (ACS) is described when myocardial ischemia occurs due to impeding blood 
flow through the coronary vessels, which in turn results in insufficient supply of oxygen. As a disease entity, 
it causes almost half of all deaths in Poland. The high mortality of ACS is primarily in the pre-hospital setting. 
The classification of acute coronary syndromes is based on criteria such as clinical symptoms, the nature 
and type of changes in the electrocardiogram, and indicators of myocardial necrosis. In the conditions of 
the emergency medical team, the division is based on the image of the ECG test. On this basis, ACS with 
elevation of the ST segment (STEMI) and without ST segment elevation (NSTEMI) are defined. Pre-hospital 
diagnosis of ACS includes an interview with the patient and a 12-lead ECG performed preferably in no more 
than 10 minutes since the first medical contact. The task of the emergency medical team is to quickly rec-
ognize, perform teletransmission to the interventional cardiology centre and implement pharmacological 
treatment, and then provide transport to the nearest centre of invasive cardiology, where the procedure 
should be performed to clear the blocked coronary artery. Therefore, it is important that the staff of medical 
emergency teams have appropriate knowledge and proper equipment for ambulances.
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INTRODUCTION
Ischemic heart disease (IHD) is the single most com-
mon cause of death in the world, and its prevalence 
increases regularly, while in Europe, over the past 
three decades, there has been a general trend to-
wards reducing mortality caused by this disease [1]. 
Statistics show that there are almost 1.8 million 
deaths annually caused by IHD, which is 20% of all 
deaths in Europe, but there is considerable variation 
in various European countries [2, 3]. Acute coro-
nary syndromes are a group of clinical syndromes 
in which sudden myocardial ischemia occurs. These 
syndromes as part of cardiovascular disease (CVD), 
in recent years, according to the Central Statistical 
Office, were reported as the cause of almost half of 
all deaths in Poland. According to the sources of the 
Central Statistical Office, in 2015, coronary artery 
disease caused the death of 10.2/10,000 people, 
including acute myocardial infarction 3.6/10,000 in-
habitants [4]. Despite the observed downward trend 
in the number of deaths as a result of CVD, mortality 
remains high and it should be noted that in contrast 
to a significant reduction in in-hospital mortality, 
out-of-hospital mortality remains relatively high [5]. 
Therefore, early diagnosis and implementing the ap-
propriate treatment as soon as possible is extremely 
important. Emergency medical teams, as the first 
in contact with the patient, can start to perform 
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the appropriate tasks, starting from the interview 
and performing the ECG, interpreting the record, 
recognizing ACS, teletransmission and giving appro-
priate pharmacology.
GENERAL DEFINITION AND CLASSIFICATION 
OF ACUTE CORONARY SYNDROMES
An acute coronary syndrome is recognized when 
myocardial ischemia occurs due to impeding blood 
flow through the coronary vessels, which in turn 
results in insufficient supply of oxygen [6−8]. When 
cardiomyocyte necrosis occurs as a result of myocar-
dial ischemia, it is recognized as acute myocardial 
infarction (AMI). The concept of acute myocardial 
infarction should only be used in situations where 
evidence of myocardial injury has been obtained 
(defined as an increase in cardiac troponin concen-
trations ≥ 1 above the upper limit of normal values 
at the 99th percentile) with necrosis in a clinical 
situation corresponding to myocardial ischemia [9]. 
Taking into account the clinical symptoms, the na-
ture and type of changes in the electrocardiogram 
and indicators of muscle necrosis, it can be distin-
guished:
• Elevation of the ST segment, where the clot com-
pletely and suddenly closes the lumen of the 
coronary artery. Myocardial necrosis begins to 
develop within 15−30 minutes after the blood 
flow stops and progresses from the subendo-
cardium to the epicardium. The time of necrosis 
depends on the diameter of the closed vessel and 
collateral circulation.
• No ST segment elevation (NSTEMI, NSTE-ACS, 
non-ST elevation acute coronary syndrome). 
It often occurs as a consequence of unstable 
angina. The infarcted area usually has a fairly 
well developed collateral circulation or is small 
(i.e., provided by a distal segment of the coro-
nary artery). The presence of Q waves [8, 10, 11] 
is also not observed.
• Unstable angina pectoris (UA), in which despite 
the characteristic clinical symptoms of myocar-
dial ischemia, there are no electrocardiographic 
changes or an increase in the index of myocar-
dial necrosis.
• Indefinite myocardial infarction, i.e. one in which 
the ECG was performed after 24 hours from the 
beginning of the symptoms and in the ECG itself 
there are such changes that cause difficulties in 
the diagnosis of ST segment elevation.
• Sudden cardiac death [6, 8].
In addition to the previously mentioned classifi-
cations, the differentiation of myocardial infarctions 
is also considered taking into account differences in 
pathogenesis, clinical picture and prognosis, as well 
as in various therapeutic procedures (Tab. 1).
Describing individual classifications of acute cor-
onary syndromes with ST segment elevation the 
division of infarcts caused by the myocardial injury 
zone cannot be omitted. This is how the sharp fail-
ures located in the bottom wall, front wall, side wall 
and back wall can be distinguished (Tab. 2).
In the case of ST segment elevation in leads II, III 
and aVF, it is necessary to perform a modified ECG 
recording the leads on the right side of the chest. 
They get the name V1R, V2R, V3R, V4R, V5R, V6R. 
One should look for ST segment elevation at the 
J point in V3R and V4R leads by min. 0.05 mV (i.e. 
0.5 mm) (in the case of men before 30 years of age 
0.1 mV, i.e. 1 mm), which signifies a right ventricu-
lar infarction.
Table 1. Classification of myocardial infarction. Own study based on [10–12]
Classification of myocardial infarction
Type I Spontaneous myocardial infarction — associated with atherosclerotic plaque rupture and ulceration; erosion 
or dissection of the arterial wall, leading to the formation of a thrombus in the light of a few or one coronary 
arteries, which results in decreased blood flow through the myocardium or embolism of blood platelets and 
consequences in the form of necrosis of cardiomyocytes
Type II Infarction as a result of inequalities between the supply of oxygen and the need for myocardial oxygen. Such 
inequality may occur due to a different reason than coronary artery disease. For example, contraction of the 
coronary artery, brady — or tachyarrhythmia, anemia, respiratory failure
Type III Myocardial infarction is not confirmed by biomarker concentration
Type IVa PCI-related stroke (percutaneous coronary intervention)
Type IVb A heart attack associated with stent thrombosis
Type V Myocardial infarction associated with CABG (coronary artery bypass graft)
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CAUSES OF ACS
There may be many reasons for the appearance of 
ACS, however the most frequent reason contribut-
ing to the occurrence of myocardial ischemia is the 
separation of an atherosclerotic plaque in the coro-
nary arteries. Other causes include: coronary artery 
spasm, coronary artery embolism, coronary artery 
inflammation and changes in them resulting from 
disturbances in the course of metabolism, coronary 
vascular defects, coronary artery injury, etc. [8]
As a result of coronary risk factors, including 
hypercholesterolemia, diabetes, hypertension and 
smoking, large and medium vessels are damaged by 
progressive atherosclerotic processes. It involves the 
formation of internal vessels in the inner membrane, 
the so-called unstable atherosclerotic plaques. Their 
formation leads to the development of inflammatory 
states, and this initiates changes at the cellular level 
and predisposes to the formation of thrombi [7, 8].
Symptoms of ACS
The main symptom of ACS is increased chest pain, 
which lasts > 20 minutes. The pain in the course of 
a coronary episode has the character of a choking, 
pressure, strangling pain, most often located in sub-
sternal area and with radiation of pain to the left up-
per limb, neck and mandible. It can be a continuous 
pain or occur intermittently. In addition, you can ob-
serve non-specific symptoms such as localized pain 
in the upper abdomen instead of the chest, nausea, 
vomiting, fainting, paleness, sweating, tachycardia, 
cardiac arrest or an asymptomatic course. The group 
of patients at risk of non-specific symptoms include 
women, the elderly, diabetics or people after surgi-
cal procedures [6, 7, 9, 14−16].
Diagnostic criteria for ACS
Diagnosis of ACS is a multi-stage process. You 
should not confirm or exclude ACS based on just 
one symptom. The interview plays a key role in the 
proper assessment of the patient’s condition. A cor-
rectly collected history can properly target and help 
you choose the right diagnostic and therapeutic 
path [7]. 
The next stage in the diagnosis of ACS is the 
fastest (preferably within 10 min of the first medical 
contact) performance and interpretation of a 12-
lead resting ECG. To recognize ACS in the form of 
STEMI, the following criteria should be adopted 
[12, 14, 18]:
• ST segment elevation at point J in any lead ex-
cept V2–V3 by a minimum of 0.1 mV (i.e.1 mm)
• ST segment elevation in V2-V3 leads with a min-
imum of:
1) 0.25 mV (i.e. 2.5 mm) for men before 40 years 
of age
2) 0.2 mV (i.e. 2 mm) for men over 40 years of age
3) 0.15 mV (i.e. 1.5 mm) for women regardless 
of age.
The criteria described above, however, do not 
apply to patients who may have features of left 
ventricular hypertrophy or left bundle branch block 
(LBBB). However, if you suspect acute myocardial is-
chemia and simultaneous presence of LBBB or RBBB 
(right bundle branch block), it is recommended to 
implement such procedures as in patients with ST 
segment elevation [14, 15].
In ACS NSTEMI, ECG changes can be very subtle 
or even completely absent. However, if they occur, 
they present as:
• ST segment depression
• Transient ST elevation and T-wave changes.
It should be remembered that a correct ECG 
recording is not a basis for exclusion of ACS. In 
a situation where symptoms continue or recur, it is 
useful to repeat the ECG recording or compare the 
current one with the previous ones [7, 10, 11, 15].
In pre-hospital situations, ACS diagnosis is based 
on the above diagnostic criteria. Therefore, it is 
important that the personnel of emergency med-
ical teams are well trained, and ambulances are 
equipped with the appropriate equipment enabling 
rapid diagnostics, ECG and, if necessary, teletrans-
mission and pharmacology [18]. The contemporary 
Table 2. Infract location. Own study based on [13]
I
Side or front wall
aVR V1
Front wall
V4
Front wall
II
Lower wall
aVL
Side or front wall
V2
Front wall
V5
Front wall
III
Lower wall
aVF
Lower wall
V3
Front wall
V6
Side or front wall
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role of the members of the emergency medical team 
should not only be limited to a quick determination 
of the initial diagnosis or ensuring an efficient pa-
tient transport with ACS to the hospital. Physicians 
and paramedics in their positions also play an ex-
tremely important role in the initiation of therapy for 
patients with ACS, especially antiplatelet therapy [6].
Pre-hospital treatment of ACS
The medical rescue team, after recognizing the 
symptoms of ACS and confirming them with the 
above diagnostic criteria, should transport the pa-
tient (semi-recumbent) to the nearest centre of in-
vasive cardiology in the shortest possible time. The 
affected artery should be unblocked within 60 min-
utes from the first medical contact with the patient 
(this applies to ACS patients with STEMI and NSTEMI 
with high-risk symptoms such as hemodynamic in-
stability, recurrent or refractory coronary pain, or 
life-threatening cardiac arrhythmias). In the case 
of patients with NSTEMI, the time that can elapse 
from the first medical contact to the implementa-
tion of invasive procedures in the hemodynamic 
laboratory is: > 24 hours in patients at high risk 
and > 72 hours in patients with intermediate risks 
e.g. diabetes, renal insufficiency [4, 7, 18]
The tasks of the emergency medical team include 
pain management, administration of nitrates, ad-
ministration of antiplatelet drugs and appropriate 
oxygen therapy [4, 6, 13]:
• In the analgesic treatment of ACS, intravenous 
morphine is most often used, however, special 
attention should be drawn to patients with 
consciousness impairments or bradycardia. The 
administration of NSAIDs (non-steroidal anti-in-
flammatory drugs) should be discontinued in the 
case of ACS as they have a pro-thrombotic effect.
• Nitrates. The routine use of nitrates in STEMI in 
a randomized controlled clinical trial compared 
to placebo did not show benefit and is therefore 
not currently recommended [19, 20]. Intrave-
nous nitrates may be useful in the acute phase 
in patients with hypertension or heart failure, 
however, under conditions of no hypotension, 
right ventricular infarction and absence of type 
5 phosphodiesterase inhibitors in the previous 
48 hours. Nitrates remain valuable drugs for 
long-term treatment in order to reduce residual 
angina symptoms. 
• Antiplatelet therapy is an extremely important 
element of pre-hospital therapy and should be 
implemented almost immediately after confir-
mation of STEMI in the ECG. Antiplatelet therapy 
should include:
1) Administration of saturated doses of ASA 
(acetylsalicylic acid). The first dose should be 
150−300 mg and be given as an easily ab-
sorbed uncoated tablet, then 75−100 mg/day
2) The second drug is the P2Y12 inhibitor. The 
recommended preparation is ticagrelor (at 
a dose of 180 mg) or clopidogrel (at a dose of 
300−600 mg) [5, 19].
• Oxygen therapy in ACS is currently not recom-
mended as a standard treatment for any patient 
with ACS because it has been shown that excess 
oxygen can be detrimental to the patient and 
can increase the area of  myocardial injury. It 
is recommended to use oxygen therapy in pa-
tients with significant hypoxemia (SpO2 < 90%) 
[5, 15, 19, 20].
In addition, it is important to constantly monitor 
the patient’s heart rhythm, and if ventricular fibrilla-
tion occurs — initiate a resuscitation algorithm [8].
SUMMARY
A well-developed emergency notification system as 
well as trained and well-equipped emergency med-
ical team are crucial in the emergency response to 
a patient with chest pain. It is therefore reasonable 
FIGURE 1. STEMI lower wall. Limb leads. Author’s own material
FIGURE 2. STEMI lower wall. Precordial leads. Author’s own 
material
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that all members of emergency medical teams are 
trained in the diagnosis of AMI symptoms, admin-
istration of oxygen if necessary, pain control as well 
as the use of advanced resuscitation activities [21]. 
Rapid pre-hospital diagnosis and diagnosis of STEMI 
as well as appropriate treatment and prompt trans-
port for rescue PCI have undoubtedly a significant 
impact on the reduction of patients’ mortality [22].
Diagnostics and therapy of patients with suspect-
ed ACS are a challenge at every stage of the proce-
dure. It is believed that properly trained medical staff 
and the use of diagnostic and therapeutic algorithms 
can contribute to therapeutic success, and hence, 
reduction of mortality in patients with ACS during 
the first contact of the patient with a medical pro-
fessional. The use of the ECG teletransmission system 
and teleconsultation by emergency medical teams 
should be standard treatment in all patients with 
suspected ACS [23], because the use of consultation 
capabilities facilitates the rapid diagnosis of STEMI 
and NSTEMI-ACS, allowing early implementation of 
DAPT in all patients who require it. In addition, it 
improves logistics and reduces the delay of revascu-
larization treatment [5]. The education of the society 
and appropriate prevention are also important.
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